A pharmacist can’t take a call from a doctor to fill a prescription for a patient, because they’re too busy playing one.
Pharmacist busy giving a “shot” to a customer.
Unbelievable. We live in a topsy turvy world now.
@gcfmd@PagingDoctorT Revisit dose titrations again in the future as well. May be able to achieve target dose down the road even if initially unable to do so
Only 15% of HFrEF 👤 were on quad 🛟 therapy ⁉️only…
❤️🩹 43% on ARNI
❤️🩹 28% on MRA
❤️🩹 35% on SGLT
with the main reason for non-GDMT being 👩🏼⚕️ 👨🏼⚕️ reporting 👤 stability ⁉️
Stable is 🚫 optimised
🔑 With a ☠️ rate of 50-75% at 5yrs post 🏥 we need to do more
#ESCCongress #MedTwitter #CardioTwitter @SJGreene_md@gcfmd
Your party is promoting:
- book banning
- limiting speech in classrooms
- silencing people in the boardroom
- fining librarians
But please tell us more about your version of “freedom of speech.”
#HeartFailure Drug Treatment – Inertia, Titration and Discontinuation: A Multinational Observational Study (#EVOLUTION HF)
After #GDMT initiation, target dose
achievement were often low and
discontinuation rates were high
Few patients received target doses of #GDMTs after 1 yr
With this post-hoc analysis in @JAMACardio showing similar results in one of our higher risk populations, where should aspirin be used for long term prevention? What situations are you using ASA as your preferred anti platelet agent?
For new onset HFrEF is there a conflict between GDMT and revascularization?
There is no definitive trial to answer this question but can the recent REVIVED and STRONG-HF trials provide guidance?
❓What do you think❓
Check out our opinion piece👇🏾
https://t.co/blsWuohCXn
If you’re interested in joining an awesome cardiology team in Philadelphia check out our posting. Lots of patient care time and collaborative efforts going on
https://t.co/5wQUKRveB1